Clover jabs Hong Kong market with HK$2bn IPO

Mainland-based Clover Biopharmaceuticals has started pitching investors for its up to HK$2.03bn ($260.5m) IPO, opening bookbuilding in Hong Kong on Monday. The company, which is developing a Covid-19 ... ( read original story ...)

Asifma urges Hong Kong to ease Covid rules

In an open letter to Paul Chan, Hong Kong's financial secretary, on Monday, Asifma called for a clear roadmap for exiting the city's 'zero-case' Covid strategy. Among the top financial cities in the ... ( read original story ...)